started · updated
SARS-CoV-2 PJ. 2. 1 variant spreads globally with higher contagion potential
A new SARS-CoV-2 variant, designated PJ. 2. 1, is circulating globally and shows a potential for faster transmission. The variant was first identified in Canada in May and has since spread to the United States, Europe, Australia, New Zealand, Israel, and Brazil.
Research published in News Medical Life Sciences indicates that the PJ. 2. 1 spike protein has a higher affinity for the ACE2 receptor, allowing it to bind to and penetrate human cells more effectively. Despite this increased transmissibility, the symptoms and severity of the disease appear consistent with previous strains.
Current vaccines remain effective against this variant. However, experts, including Markus Hoffmann from the German Primate Center, warn that further mutations could eventually allow the virus to evade the immune response provided by existing vaccinations.
Entities
German Primate Center · Markus Hoffmann · News Medical Life Sciences · PJ. 2. 1 · World Health Organization